Research Options:
Week of Expected Pricing Withdrawn
Company Name INHIBRX, INC
Proposed Ticker INBX
CUSIP N/A
Business Description A clinical-stage biotechnology company focused on developing a broad pipeline of novel biologic therapeutic candidates.
Lead Underwriter Barclays Capital Inc,Evercore Group L.L.C
Co-Managers Nomura Securities International, Inc.,Raymond James and Associates, Inc.
Initial Shares N/A
Revised Initial Shares N/A
Initial Price N/A
Revised Price N/A
Final Price N/A
Final Ticker N/A

 

 
   
  © 2024 ICE Data Services. All rights reserved.